Back to Search Start Over

Preparation and evaluation of 188 Re sulfide colloidal nanoparticles loaded biodegradable poly (L-lactic acid) microspheres for radioembolization therapy.

Authors :
Jamre M
Shamsaei M
Erfani M
Sadjadi S
Ghannadi Maragheh M
Source :
Journal of labelled compounds & radiopharmaceuticals [J Labelled Comp Radiopharm] 2018 Jun 30; Vol. 61 (8), pp. 586-594. Date of Electronic Publication: 2018 May 04.
Publication Year :
2018

Abstract

Radioembolization with radioactive microspheres has been an effective method for the treatment of liver lesions. The aim of this study was to prepare carrier-free <superscript>188</superscript> Re loaded poly (L-lactic acid) (PLLA) microspheres through <superscript>188</superscript> Re sulfide colloidal nanoparticles ( <superscript>188</superscript> Re-SC nanoparticles). The formation of <superscript>188</superscript> Re-SC nanoparticles was confirmed by ultraviolet-visible spectrophotometry. The labeling yield of <superscript>188</superscript> Re-SC nanoparticles was verified using the RTLC method. Effects of synthesis parameters on morphology and size of prepared <superscript>188</superscript> Re-sulfide colloidal-PLLA microspheres ( <superscript>188</superscript> Re-SC-PLLA microspheres) were studied by scanning electron microscopy. In vitro stability of <superscript>188</superscript> Re-SC-PLLA microspheres was investigated in normal saline at room temperature and in human serum at 37°C. In vivo distribution studies and gamma camera imaging were performed in healthy BALB/c mice. The microspheres could be prepared with sizes between 13 and 48 μm (modal value 29 μm) and radiolabeling efficiency >99%. After incubation, the microspheres were found stable in vitro up to 72 hours. The biodistribution after intravenous injection in healthy BALB/c mice showed high accumulation in lung as a first capture pathway organ for microsphere followed by great retention over 48 hours for these microspheres. These data show that <superscript>188</superscript> Re-SC-PLLA microspheres are suitable candidate for clinical studies.<br /> (Copyright © 2018 John Wiley & Sons, Ltd.)

Details

Language :
English
ISSN :
1099-1344
Volume :
61
Issue :
8
Database :
MEDLINE
Journal :
Journal of labelled compounds & radiopharmaceuticals
Publication Type :
Academic Journal
Accession number :
29644706
Full Text :
https://doi.org/10.1002/jlcr.3627